小剂量肝素联合病毒唑雾化吸入治疗喘憋性肺炎疗效观察

Effective observation on asthmatic pneumonia in treatment of low dose heparin and virazole aerosol inhalation

目的:观察小剂量肝素联合病毒唑雾化吸入治疗喘憋性肺炎的临床效果。方法:将180例喘憋性肺炎患儿随机分成治疗组90例和对照组90例,两组均在常规处理基础上,治疗组予肝素、病毒唑超声雾化吸入治疗;对照组予常规α-糜蛋白酶、地塞米松雾化吸入治疗,对治疗后两组患儿在症状与体征消失、X线吸收情况及住院时间等方面进行疗效对比。结果:治疗组在咳嗽消失、喘憋消失、啰音消失、X线吸收情况及住院时间等方面效果均明显优于对照组(P<0.05)。治疗组总有效率为93.33%,明显高于对照组的72.22%。结论:小剂量肝素联合病毒唑雾化吸入治疗喘憋性肺炎疗效确切,能较大地提高治愈率,且价廉、安全、方便、副作用少,值得临床推广。

Objective： To observe clinical effects on asthmatic pneumonia in treatment of low dose heparin and virazole aerosol inhalation.Methods： 180 patients with asthmatic pneumonia were divided into two groups at random,the treatment group（90 cases） received low dose heparin and virazole aerosol inhalation;while the control group（90 cases） received α-chymotrypsin and dexamethasone.After treatment the clinical efficacy of both groups was observed and compared,which in the disappearance of symptoms and signs,X-ray absorption and hospitalization time.Results： In treatment group clinical symptoms,rales from lungs,X-ray absorption and hospitalization time were decreased obviously,as compared with that of control group（P〈0.05）.Also the total effective rate of treatment group（93.33%） was significantly higher than control group（72.22%）.Conclusion： The clinical effects of asthmatic pneumonia in treatment of low dose heparin and virazole aerosol inhalation was curative,which can enhance the curative rate,and can be used extensively.